DAVITA INC. Goodwill, Impaired, Accumulated Impairment Loss
DAVITA INC. (DVA) had Goodwill, Impaired, Accumulated Impairment Loss of $153.40 million as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Notes › Goodwill and Other › Goodwill, Impaired, Accumulated Impairment Loss
us-gaap:GoodwillImpairedAccumulatedImpairmentLoss · last filed 2026-08-04
- 2026-06-30: Goodwill, Impaired, Accumulated Impairment Loss $153.40M.
- 2026-03-31: Goodwill, Impaired, Accumulated Impairment Loss $154.26M.
- 2025-12-31: Goodwill, Impaired, Accumulated Impairment Loss $156.74M.
- 2025-09-30: Goodwill, Impaired, Accumulated Impairment Loss $156.59M.
| Period end | Goodwill, Impaired, Accumulated Impairment Loss |
|---|---|
| 2026-06-30 | $153.40M 10-Q · filed 2026-08-04 |
| 2026-03-31 | $154.26M 10-Q · filed 2026-05-05 |
| 2025-12-31 | $156.74M 10-K · filed 2026-02-11 |
| 2025-09-30 | $156.59M 10-Q · filed 2025-10-29 |
| 2025-06-30 | $156.58M 10-Q · filed 2025-08-05 |
| 2025-03-31 | $146.61M 10-Q · filed 2025-05-12 |
| 2024-12-31 | $141.82M 10-K · filed 2025-02-13 |
| 2024-09-30 | $150.26M 10-Q · filed 2024-10-29 |
| 2024-06-30 | $145.50M 10-Q · filed 2024-08-06 |
| 2024-03-31 | $146.50M 10-Q · filed 2024-05-02 |
| 2023-12-31 | $149.10M 10-K · filed 2024-02-14 |
| 2023-09-30 | $117.94M 10-Q · filed 2023-11-07 |
| 2023-06-30 | $121.22M 10-Q · filed 2023-08-03 |
| 2023-03-31 | $120.91M 10-Q · filed 2023-05-08 |
| 2022-12-31 | $118.99M 10-K · filed 2023-02-22 |
| 2022-09-30 | $109.33M 10-Q · filed 2022-10-31 |
| 2022-06-30 | $116.56M 10-Q · filed 2022-08-01 |
| 2022-03-31 | $123.94M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $126.21M 10-K · filed 2022-02-11 |
| 2021-09-30 | $128.99M 10-Q · filed 2021-10-28 |
| 2021-06-30 | $132.15M 10-Q · filed 2021-08-03 |
| 2021-03-31 | $130.57M 10-Q · filed 2021-04-29 |
| 2020-12-31 | $136.55M 10-K · filed 2021-02-12 |
| 2020-09-30 | $130.43M 10-Q · filed 2020-10-29 |
| 2020-06-30 | $125.17M 10-Q · filed 2020-07-30 |
| 2020-03-31 | $148.48M 10-Q · filed 2020-05-05 |
| 2019-12-31 | $153.34M 10-K · filed 2020-02-21 |
| 2019-09-30 | $149.74M 10-Q · filed 2019-11-07 |
| 2019-06-30 | $68.60M 10-Q · filed 2019-08-02 |
| 2019-03-31 | $68.01M 10-Q · filed 2019-05-07 |
| 2018-12-31 | $27.27M 10-K · filed 2019-02-22 |
| 2018-09-30 | $27.60M 10-Q · filed 2018-11-07 |
| 2018-06-30 | $34.28M 10-Q · filed 2018-08-01 |
| 2018-03-31 | $70.52M 10-Q · filed 2018-05-03 |
| 2017-12-31 | $70.52M 10-K · filed 2018-02-23 |
| 2017-09-30 | $1.16B 10-Q · filed 2017-11-07 |
| 2017-06-30 | $561.41M 10-Q · filed 2017-08-01 |
| 2017-03-31 | $500.29M 10-Q · filed 2017-05-02 |
| 2016-12-31 | $476.09M 10-K · filed 2017-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |